1,3-dipropyl-8-cyclopentylxanthine has been researched along with Anochlesia in 4 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In addition, this series of compounds has demonstrated good bioavailability and in vivo efficacy in a rodent model of Parkinson's disease, despite having reduced potency for the rat A2A receptor versus the human A2A receptor." | 1.35 | Identification of novel, water-soluble, 2-amino-N-pyrimidin-4-yl acetamides as A2A receptor antagonists with in vivo efficacy. ( Castro-Palomino, JC; Chen, Y; Crespo, MI; Díaz, JL; Gross, RS; Gual, S; Joswig, T; Lanier, MC; Lechner, SM; Lin, E; Malany, S; Markison, S; Moorjani, M; O'Brien, Z; Prat, M; Rueter, JK; Santos, M; Saunders, J; Slee, DH; Wen, J; Williams, JP; Zhang, X, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Slee, DH | 1 |
| Zhang, X | 1 |
| Moorjani, M | 1 |
| Lin, E | 1 |
| Lanier, MC | 1 |
| Chen, Y | 1 |
| Rueter, JK | 1 |
| Lechner, SM | 1 |
| Markison, S | 1 |
| Malany, S | 1 |
| Joswig, T | 1 |
| Santos, M | 1 |
| Gross, RS | 1 |
| Williams, JP | 1 |
| Castro-Palomino, JC | 1 |
| Crespo, MI | 1 |
| Prat, M | 1 |
| Gual, S | 1 |
| Díaz, JL | 1 |
| Wen, J | 1 |
| O'Brien, Z | 1 |
| Saunders, J | 1 |
| Varty, GB | 1 |
| Hodgson, RA | 1 |
| Pond, AJ | 1 |
| Grzelak, ME | 1 |
| Parker, EM | 1 |
| Hunter, JC | 1 |
| Stasi, MA | 1 |
| Borsini, F | 1 |
| Varani, K | 1 |
| Vincenzi, F | 1 |
| Di Cesare, MA | 1 |
| Minetti, P | 1 |
| Ghirardi, O | 1 |
| Carminati, P | 1 |
| Mandhane, SN | 1 |
| Chopde, CT | 1 |
| Ghosh, AK | 1 |
4 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Anochlesia
| Article | Year |
|---|---|
Identification of novel, water-soluble, 2-amino-N-pyrimidin-4-yl acetamides as A2A receptor antagonists with in vivo efficacy.
Topics: Acetamides; Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Catalepsy; Cell Line; | 2008 |
The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates.
Topics: Adenosine A2 Receptor Antagonists; Animals; Antipsychotic Agents; Caffeine; Catalepsy; Cebus; Corpus | 2008 |
ST 1535: a preferential A2A adenosine receptor antagonist.
Topics: Adenine; Adenosine A2 Receptor Antagonists; Animals; Behavior, Animal; Catalepsy; CHO Cells; Criceti | 2006 |
Adenosine A2 receptors modulate haloperidol-induced catalepsy in rats.
Topics: 2-Chloroadenosine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Catalepsy; Dopamine Antago | 1997 |